Clinical trial
Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular…
NCT02034019 · Ocular Therapeutix, Inc., Industry · Completed
Key facts
| NCT number | NCT02034019 |
|---|---|
| Title | Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery |
| Lead sponsor | Ocular Therapeutix, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Post Ocular Surgical Inflammation and Pain |
| Intervention type | Drug |
| Interventions | Dexamethasone, Punctum Plug |
| Enrollment | 247 |
| Start date | Feb 1, 2014 |
| Primary completion | Dec 1, 2014 |
| Completion | Feb 1, 2015 |
| First posted | Jan 13, 2014 |
| Last update posted | Jan 31, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: